July 6, 2021 – The first SE Color Pitch event, hosted by Southeast Life Sciences, was held on June 24, 2021, featuring top minority-led, early-stage life science companies from the southeast United States.
TruGenomix is a precision behavioral health company focused on advancing the diagnosis and treatment of mental health conditions such as post-traumatic stress disorder (PTSD). Our behavioral health platform incorporates our core products, TruGen-1and TruBase. TruGen-1 is a 1000 gene neuropsychiatric panel, designed in collaboration with Illumina, that includes our patented markers for PTSD predisposition. TruBase is our custom-built machine learning and bioinformatics engine, which is designed to support behavioral health research, clinical decision-making, and biomarker discovery.
See the presentation HERE.
Congratulations Charles & TruGenomix!
About SE Color
SE Color, a division of Southeast Life Sciences, was established in 2020. SE Color is an organization designed to support minority life science entrepreneurship, increase investment in minority-owned life science businesses, and improve minority access to information and clinical opportunities.
About Southeast Life Sciences
In 2019, the Southeastern Medical Device Association (SEMDA) and Southeast BIO (SEBIO) officially merged to form Southeast Life Sciences. The merger created a single, unified platform for medtech and bioscience innovation, partnering and investor relations.